Objective:
We aimed to estimate the long-term outcomes of transthoracic Heller's myotomy without fundoplication.
Methods:
This single centere, retrospective study included patients followed up for signs of cure, recurrence of symptoms, and different aspects of quality of life estimated over several years. Data were obtained directly from the patients and the medical records. The scores of patients with early and late dysphagia were compared preoperatively and postoperatively to estimate the quality of life (QoL).
Results:
A total of 48 patients (37 women and 11 men) who underwent surgery for achalasia between 2008 and 2018 were included. The mean age was 43.5 (19–68) years. The mean follow-up duration was 60.5 (1–120) months. Dysphagia, regurgitation, and heartburn were the most common symptoms, occurring in 100% of patients. The outcomes were an excellent success rate and estimation of QoL. After the first 6 months of follow-up, patients who underwent surgery developed grades 1–3 dysphagia. After 1–10 years of follow-up, 39 (81.25%) patients had grade 1 dysphagia, whereas 9 (18.75%) still had grade 2 dysphagia. During the long-term follow-up, only 77% of patients developed regurgitation, while 91.6% had heartburn. QoL changed according to dysphagia scores (from 5 to 1). However, the score of 26 patients (54.16%) decreased to 1; after 1 year of follow-up, 42 patients (87.5%) obtained a dysphagia score of 1. After 1–10 years of follow-up, 97.2% of patients underwent barium oesophagogram and showed a small-calibre oesophagus.
Conclusion:
Transthoracic Heller's myotomy is a safe and durable procedure that is associated with a durable long-term success rate and less recurrence, without necessity for any type of anti-reflux surgery.
Highlights: